Modifications of blood platelet proteins of patients with schizophrenia

Platelets

Volumn 20, Issue 2, 2009, Pages 90-96

  Dietrich Muszalska, Anna ^a   Olas, Beata ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

3 nitrotyrosine; Blood platelets; Carbonyl group; Oxidative nitrative stress; Schizophrenia; Thiol group

Indexed keywords

3 NITROTYROSINE; 5,5' DITHIOBIS(2 NITROBENZOIC ACID); BIOLOGICAL MARKER; CARBONYL DERIVATIVE; CELL PROTEIN; OLANZAPINE; QUETIAPINE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RISPERIDONE; THIOL DERIVATIVE; THROMBOCYTE PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; NERVE CELL; NITRATIVE STRESS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN MODIFICATION; SCHIZOPHRENIA; THROMBOCYTE;

ADULT; BLOOD PLATELETS; BLOOD PROTEINS; FEMALE; HUMANS; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; QUESTIONNAIRES; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SCHIZOPHRENIA; TYROSINE;

EID: 61649120620     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100802641499     Document Type: Article

References (45)

1. Bartosz G. Peroxynitrite: Mediator of the toxic action of nitric oxide. Acta Biochim Pol 1996;43:645-659.
2. Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem. Biophys Res Commun 2003;305:776-783.
3. Ischiropoulos H, Gow A. Pathophysiological functions of nitric oxide-mediated protein modifications. Toxicology 2005;208:299-303.
4. Patel RP, McAndrew J, Sellak H, White CR, Jo H, Freeman BA, Darley-Usmar VM. Biological aspects of reactive nitrogen species. Biochim Biophys Acta 1999;1411:385-400.
5. Berk M, Plein H, Czismadia T. Super-sensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia. Int Clin Psychopharmaced 1999;14:119-122.
6. Berk M, Plein H, Belsham B. The specificy of platelet glutamate receptor supersensitivity in psychotic disorders. Life Sci 2000;66:2427-2432.
7. Plein H, Berk M. The platelet as a peripheral marker in psychiatric illness. Human Psychopharmacol Clin Exp 2001;16:229-236.
8. Bakken AM, Staeffler A, Jorgensen HA, Holmsen H. Glycerophospholipid molecular species in platelets and brain tissues - are platelets a good model for neurons? Platelets 2006;17:484-492.
9. Dietrich-Muszalska A, Olas B, Rabe-Jablonska J. Oxidative stress in blood platelets from schizophrenic patients. Platelets 2005;16:386-391.
10. Dietrich-Muszalska A, Olas B. Isoprostanes as indicators of oxidative stress in schizophrenia. World J Biol Psychia 2007;4:1-6.
11. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59:22-33.
12. Walkowiak B, Michalak E, Koziolkiewicz W, Cierniewski CS. Rapid photometric method for estimation of platelet count in blood plasma or platelet suspension. Thromb Res 1989;56:763-766.
13. Ando Y, Steiner M. Sulfhydryl and disulfide groups of platelet membranes: determination of disulfide groups. Biochim Biophys Acta 1973;311:26-37.
14. Ando Y, Steiner M. Sulfhydryl and disulfide groups of platelet membranes: Determination of sulfhydryl groups. Biochim Biophys Acta 1993;311:38-44.
15. Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC. Protein carbonyl measurement by a sensitive ELISA method. Free Rad Biol Med 1997;23:361-366.
16. Olas B, Nowak P, Ponczek M, Wachowicz B. Natural phenolic compound - resveratrol may reduce carbonylation of proteins induced by peroxynitrite in blood platelets. General Physiol Biophys 2006;25:215-222.
17. Khan J, Brennan DM, Bradley N, Gao B, Brukdorfer R, Jacobs M. 3-Nitrotyrosine in the proteins of human plasma determined by an Elisa method. Biochem J 1998;330:795-801.
18. Olas B, Nowak P, Kolodziejczyk J, Wachowicz B. The effects of antioxidants on peroxynitrite-induced changes in platelet proteins. Thromb Res 2004;113:399-406.
19. Olas B, Żbikowska HM, Wachowicz B, Krajewski T, Buczyński A, Magnuszewska A. Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta Biochim Polon 1999;46:61-66.
20. Jahn B, Hansch GM. Oxygen radical generation in human platelets: Depence of 12-lipoxygenase activity and on the glutathione cycle. Int Arch Allergy Appl Immunol 1990;93:73-79.
21. Dietrich-Muszalska A, Rabe-Jablonska J, Zgirski A. The effects of olanzapine (Zolafren) on lipid peroxidation in human blood platelets and plasma: In vitro studies. Psychiatria i Psychologia Kliniczna 2004;4:13-19.
22. Dietrich-Muszalska A. Evaluation of the effects of different concentrations of risperidone, corresponding to the drug doses used in treatment of schizophrenic patients, on lipid peroxidation in plasma and blood platelets at in vitro studies. Psychiatria i Psychologia Kliniczna 2004;4:215-223.
23. Dietrich-Muszalska A. The impact of different concentrations of clozapine on changes of lipid peroxidation in human plasma - in vitro studies. Psychiatria i Psychologia Kliniczna 2005;1:18-25.
24. Dietrich-Muszalska A, Rabe-Jablońska J, Olas B. The effects of the second generation antipsychotics and a typical neuroleptic on collagen-induced platelet aggregation in vitro. J Physiol Pharmacol (sub.).
25. Axelsson S, Hagg S, Eriksson AC, Lindahl TL, Whiss PA. In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation. Clin Experim Pharmacol Physiol 2007;34:775-780.
26. Olas B, Wachowicz B. Role of reactive nitrogen species in blood platelet functions. Platelets 2007;18:555-565.
27. Srivastava N, Barthwal MK, Dalal PK, Agarwal AK, Nag D, Srimal RC, Seth PK, Dikshit M. Nitrite content and antioxidant enzymes levels in the blood of schizophrenic patients. Psychopharmacology 2001;158:140-145.
28. Zoroglu SS, Herken H, Yurekli M, Uz E, Tutkun H, Savas HA, Bagci C, Ozen ME, Cengiz B, Cakmak EA. et al. The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia. J Psych Res 2002;36:309-315.
29. Taneli F, Pirildar S, Akdeniz F, Uyanik BS, Ari Z. Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia. Arch Med Res 2004;35:401-405.
30. Berstein HG, Bogerts B, Keilhoff G. The many faces of nitric oxide in schizophrenia. A review. Schizoph Res 2005;78:69-86.
31. Yilmaz N, Herken H, Cicek HK, Celik A, Yureklin M, Akyol O. Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia. Med Princ Pract 2007;16:137-141.
32. Soszynski M, Bartosz G. Effect of peroxynitrite on erythrocytes. Biochim Biophys Acta 1996;1291:107-114.
33. Reiter CD, Teng RJ, Beckman JS. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol Chem 2000;259:32460-32466.
34. Bruckdorfer KR. The nitration of proteins in platelets. Life Sci 2001;324:611-615.
35. Sabetkar M, Low SY, Naseem KM, Bruckdorfer KR. The nitration of proteins in platelets: significance in platelet function. Free Rad Biol Med 2002;33:728-736.
36. Dietrich-Muszalska A, Olas B, Glowacki R, Bald E. Oxidative/ nitrative modifications of plasma proteins and thiols from patients with schizophrenia. Neuropsychobiology (in press).
37. Gambaryan S, Kobsar A, Hartmann S, Birschmann I, Kuhlencordt PJ, Muller-Esterl W, Lohmann SM, Walter U. NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclise activity. J Thromb Haemost 2008;6:1376-1384.
38. Do KQ, Trabesinger AH, Kirsten-Kruger M, Lauer CJ, Dydak U, Hell D, Holsboer F, Boesinger P, Cuenol M. Schizophrenia: Glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 2000;12:3721-3728.
39. Grima G, Benz B, Parpura V, Cuenod M, Do KQ. Dopamine-induced oxidative stress in neurons with glutathione deficit: Implication for schizophrenia. Schizophr Res 2003;62:213-224.
40. Inayama T, Oka J, Kashiba M, Saito M, Higuchi M, Umegaki K, Yamamoto Y, Matsuda M. Moderate physical exercise induces the oxidation of human blood protein thiols. Life Sci 2002;70:2039-2046.
41. Essex DW, Li M. Redox control of platelet aggregation. Biochemistry 2003;42:129-136.
42. Hansen JM, Choe HS, Carney EW, Harris C. Differential antioxidant enzyme activities and glutathione content between rat and rabbit conceptuses. Free Rad Biol Med 2001;30:1078-1088.
43. Martin C, Martinez R, Navarro R, Ruiz-Sanz JI, Lacort M, Ruiz-Larrea MB. tert-Butyl hydroperoxide-induced lipid signalling in hepatocytes: involvement of glutathione and free radicals. Biochem Pharmacol 2001;62:705-712.
44. Allebeck P, Wistedt B. Mortality in schizophrenia a ten-year follow-up based on the: Stocholm Country inpatient register. Arch Gen Psychiatry 1986;43:650-653.
45. Dietrich-Muszalska A, Olas B. The changes of aggregability of blood platelets in schizophrenia. World J Biol Psychia 2007;8:1-7.